Safety and Efficacy of Kartigen<sup>®</sup> in Treating Cartilage Defects: A Randomized, Controlled, Phase I Trial

Safety and Efficacy of Kartigen<sup>®</sup> in Treating Cartilage Defects: A Randomized, Controlled, Phase I Trial

Here, we aimed to investigate the safety and preliminary efficacy of Kartigen<sup>®</sup>, a matrix with autologous bone marrow mesenchymal stem cell-derived chondrocyte precursors embedded in atelocollagen. As a surgical graft, Kartigen<sup>®</sup> was implanted onto the car...

Full description

Bibliographic Details
Main Authors: Yen-Liang Liu, Chun-Che Yen, Tzu-Shang Thomas Liu, Chih-Hung Chang, Tiffany Ting-Fang Shih, Jyh-Horng Wang, Ming-Chia Yang, Feng-Huei Lin, Hwa-Chang Liu
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Polymers
Subjects:
cartilage defect
knee
Kartigen<sup>®</sup>
chondrocyte precursors
stem cell therapy
Online Access:https://www.mdpi.com/2073-4360/13/18/3029

Internet

https://www.mdpi.com/2073-4360/13/18/3029

Similar Items